Paper41711348
Structural Change of ApoE-Lipid Nanoparticles Alters Receptor-Mediated Endocytosis and Induces Endosomal Disruption.
Mo Y and 10 others. J Am Chem Soc, 2026. Cited by 3 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Structural Change of ApoE-Lipid Nanoparticles Alters Receptor-Mediated Endocytosis and Induces Endosomal Disruption. Papers, record 41711348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41711348
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Structural Change of ApoE-Lipid Nanoparticles Alters Receptor-Mediated Endocytosis and Induces Endosomal Disruption.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nanoparticles | Major topic |
| Endosomes | Major topic |
| Endocytosis | Major topic |
| Apolipoproteins E | Major topic |
| Lipids | Major topic |
| Humans | |
| Liposomes |
Source PubMed
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20461061 | Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. | Mol Ther | 2010 | https://conductscience.org/library/papers/20461061 | PubMed |
| 2 | 33176118 | Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis. | Neuron | 2021 | https://conductscience.org/library/papers/33176118 | PubMed |
| 3 | 32145269 | Different kinetics for the hepatic uptake of lipid nanoparticles between the apolipoprotein E/low density lipoprotein receptor and the N-acetyl-d-galactosamine/asialoglycoprotein receptor pathway. | J Control Release | 2020 | https://conductscience.org/library/papers/32145269 | PubMed |
| 4 | 38740953 | Frameworks for transformational breakthroughs in RNA-based medicines. | Nat Rev Drug Discov | 2024 | https://conductscience.org/library/papers/38740953 | PubMed |
| 5 | 9726940 | Surface specific kinetics of lipid vesicle adsorption measured with a quartz crystal microbalance. | Biophys J | 1998 | https://conductscience.org/library/papers/9726940 | PubMed |
| 6 | 32786370 | The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy. | Bioconjug Chem | 2020 | https://conductscience.org/library/papers/32786370 | PubMed |
| 7 | 36853331 | Light-Activated siRNA Endosomal Release (LASER) by Porphyrin Lipid Nanoparticles. | ACS Nano | 2023 | https://conductscience.org/library/papers/36853331 | PubMed |
| 8 | 36154076 | Lipid Nanoparticle (LNP) Chemistry Can Endow Unique In Vivo RNA Delivery Fates within the Liver That Alter Therapeutic Outcomes in a Cancer Model. | Mol Pharm | 2022 | https://conductscience.org/library/papers/36154076 | PubMed |
| 9 | 35606443 | A pyroptosis nanotuner for cancer therapy. | Nat Nanotechnol | 2022 | https://conductscience.org/library/papers/35606443 | PubMed |
| 10 | 35671473 | Universal Barcoding Predicts In Vivo ApoE-Independent Lipid Nanoparticle Delivery. | Nano Lett | 2022 | https://conductscience.org/library/papers/35671473 | PubMed |
| 11 | 11533033 | Lipid binding-induced conformational change in human apolipoprotein E. Evidence for two lipid-bound states on spherical particles. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11533033 | PubMed |
| 12 | 30375977 | Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer's disease. | Elife | 2018 | https://conductscience.org/library/papers/30375977 | PubMed |
| 13 | 28459430 | Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. | Nature | 2017 | https://conductscience.org/library/papers/28459430 | PubMed |
| 14 | 11912196 | Apolipoprotein E4 potentiates amyloid beta peptide-induced lysosomal leakage and apoptosis in neuronal cells. | J Biol Chem | 2002 | https://conductscience.org/library/papers/11912196 | PubMed |
| 15 | 24516150 | Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/24516150 | PubMed |
| 16 | 38965378 | The 60-year evolution of lipid nanoparticles for nucleic acid delivery. | Nat Rev Drug Discov | 2024 | https://conductscience.org/library/papers/38965378 | PubMed |
| 17 | 3283935 | Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. | Science | 1988 | https://conductscience.org/library/papers/3283935 | PubMed |
| 18 | 3666320 | Increased frequency of apolipoprotein epsilon 4 allele in type II diabetes with hypercholesterolemia. | Diabetes | 1987 | https://conductscience.org/library/papers/3666320 | PubMed |
| 19 | 37364130 | Lipid nanoparticle topology regulates endosomal escape and delivery of RNA to the cytoplasm. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/37364130 | PubMed |
| 20 | 34059811 | The current landscape of nucleic acid therapeutics. | Nat Nanotechnol | 2021 | https://conductscience.org/library/papers/34059811 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42915048 | Lipoprotein Corona Reshapes the Internal Structure of Lipid Nanoparticles. | ACS Nano | 2026 | https://conductscience.org/library/papers/42915048 | PubMed |
| 42677364 | Lipid Nanoparticle Protein Coronas Arise through Lipoprotein Fusion Rather Than Shell-like Adsorption. | Nano Lett | 2026 | https://conductscience.org/library/papers/42677364 | PubMed |
| 42438135 | From Morphology to Mechanism: Cryo-Electron Microscopy Insights into Lipid Nanoparticles for RNA Delivery. | ACS Nano | 2026 | https://conductscience.org/library/papers/42438135 | PubMed |
| 42180053 | A novel auto-fluorescent porphyrin-lipid nanoparticle strategy for CTNNB1 gene silencing in hepatocellular carcinoma. | Front Oncol | 2026 | https://conductscience.org/library/papers/42180053 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ANXA5 | 308 | PubTator's text mining | https://conductscience.org/library/genes/308 | NCBI Gene |
| APOE | 348 | PubTator's text mining | https://conductscience.org/library/genes/348 | NCBI Gene |
| CASP3 | 836 | PubTator's text mining | https://conductscience.org/library/genes/836 | NCBI Gene |
| GAPDH | 2597 | PubTator's text mining | https://conductscience.org/library/genes/2597 | NCBI Gene |
| HMGB1 | 3146 | PubTator's text mining | https://conductscience.org/library/genes/3146 | NCBI Gene |
| LDLR | 3949 | PubTator's text mining | https://conductscience.org/library/genes/3949 | NCBI Gene |
| PCSK9 | 255738 | PubTator's text mining | https://conductscience.org/library/genes/255738 | NCBI Gene |
| TTR | 7276 | PubTator's text mining | https://conductscience.org/library/genes/7276 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41711348
GET https://conductscience.org/api/papers/v1/41711348/references?page=2